Item No.NLM-3987-CA-20
Adenosine 5′-triphosphate, ammonium salt (¹⁵N₅, 98-99%) CP 90% (in solution)

Synonyms
Formula
CAS Number LabeledNA
CAS Number UnlabeledNA
EC Number
| Item no. | Package size | Availability | List Price (USD) | Your Price (USD) | ||
|---|---|---|---|---|---|---|
| NLM-3987-CA-20 | 20 µmol | Low stock | $350 | Your Price (USD) $350 |
Properties
Molecular Weight18.02 g/mol
Chemical Purity90%
FormIndividual
ConcentrationSolution
Application(s)Biomolecular NMR, Genetic Therapy
Storage TempStore in freezer (-20°C). Protect from light.
Product Description
Adenosine 5'-triphosphate (15N5, 98%) plays an important role providing energy in many biochemical and metabolic processes. It is also a purine nucleoside building block used for enzymatic synthesis of RNA.
Application Descriptions
Safety Information
Hazard Pictograms
Signal Word
Hazard Statement
Reviews (0)
There are no reviews yet.
Item No.NLM-3987-CA-20
Adenosine 5′-triphosphate, ammonium salt (¹⁵N₅, 98-99%) CP 90% (in solution)

Product is supplied as the ammonium salt at 100mm
(20 umol in 0.2 ml water, ph ~7.5).
Dry ice shipment required.
Synonyms
Formula
CAS Number LabeledNA
CAS Number UnlabeledNA
EC Number
| Item no. | Package size | Availability | List Price (USD) | Your Price (USD) | ||
|---|---|---|---|---|---|---|
| NLM-3987-CA-20 | 20 µmol | Low stock | $350 | Your Price (USD) $350 |
Do you need bulk quantities of this material?
Pleaseto request pricing and availability for NLM-3987-CA-20
Properties
Molecular Weight18.02 g/mol
Chemical Purity90%
FormIndividual
ConcentrationSolution
Application(s)Biomolecular NMR, Genetic Therapy
Storage TempStore in freezer (-20°C). Protect from light.
Product Description
Adenosine 5'-triphosphate (15N5, 98%) plays an important role providing energy in many biochemical and metabolic processes. It is also a purine nucleoside building block used for enzymatic synthesis of RNA.
Application Descriptions
Safety Information
Hazard Pictograms
Signal Word
Hazard Statement
Reviews (0)
There are no reviews yet.
